Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 9/20 | 0.43 |
| ▸ | HTR2B | P41595 | 9/20 | 0.43 |
| ▸ | HTR2C | P28335 | 8/20 | 0.43 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | F2R | P25116 | 2/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5135886 | 0.95 | C5AR1 (0.42) | HTR2AHTR2BHTR2CC5AR1TP53 | |
| SCHEMBL5136286 | 0.94 | HTR2A (0.48) | HTR2AHTR2BHTR2CC5AR1TP53 | |
| SCHEMBL5137323 | 0.92 | C5AR1 (0.51) | HTR2AHTR2BHTR2CC5AR1TP53 | |
| SCHEMBL5136966 | 0.92 | HTR2A (0.43) | HTR2AHTR2BHTR2CC5AR1TP53 | |
| SCHEMBL5136612 | 0.91 | C5AR1 (0.45) | HTR2AHTR2BHTR2CC5AR1TP53 | |
| SCHEMBL5135206 | 0.90 | TP53 (0.45) | HTR2AHTR2BHTR2CC5AR1TP53 | |
| SCHEMBL4766728 | 0.90 | C5AR1 (0.51) | HTR2AHTR2BHTR2CC5AR1SMN1; SMN2 | |
| SCHEMBL5136838 | 0.89 | HTR2A (0.46) | HTR2AHTR2BHTR2CC5AR1TP53 | |
| SCHEMBL5137620 | 0.88 | C5AR1 (0.42) | HTR2AHTR2BHTR2CC5AR1TP53 | |
| SCHEMBL5136199 | 0.87 | HTR2A (0.47) | HTR2AHTR2BHTR2CC5AR1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1490044-A4 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORP (US) | 2008-04-16 | — | — | EP | disclosed |
| EP-1490044-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003084524-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS | NEUROGEN CORPORATION (US) | 2003-10-16 | — | — | WO | disclosed |